Komori
Haba Laboratories (4925) · RiskReframed

Interest Rate Risk on Borrowings and Hedging with Interest Rate Swaps

First written in FY2018. 16 of 19 entries say "Restated". Latest entry: FY2026.

19entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018 – FY2020-Q3RestatedFY2021-Q1 – FY2024-Q32018: 320182019: 420192020: 420202021: 320212022: 220222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Hedging Interest Rates on Long-Term Borrowings Through Interest-Rate SwapsA theme 230 companies write about · 125 as a headwind · 99 as a tailwind

Haba Laboratories moved to the "Worse" side of this theme in 2026, 2 years after the typical company in this theme (2024).

The whole theme swung hardest in 2025: 11 of 65 companies on the "Worse" side.

4 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 234 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「The company addresses interest rate fluctuation risk on borrowings by monitoring market interest rate trends as necessary.」

    The disclosure has changed from hedging through interest rate swaps to measures centered on monitoring market interest rate trends.
  2. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  3. FY2023-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  4. FY2023-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  5. FY2022-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  6. FY2022-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  7. FY2022-Q1RestatedAnnual report

    「No new business or other risks arose during the first quarter of the current consolidated cumulative period. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  8. FY2021-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative first nine months of the consolidated fiscal year. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  9. FY2021-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  10. FY2021-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  11. FY2020SoftenedAnnual report

    「Borrowings are primarily used to finance capital expenditures.」

    Borrowings for capital expenditures are still disclosed, but the specific reference made in the previous fiscal year to variable interest rate risk and mitigation through interest rate swaps is no longer included.
  12. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  13. FY2020-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  14. FY2020-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  15. FY2019RestatedAnnual report

    「Borrowings are primarily used to finance capital expenditures, and most are at variable interest rates, exposing the company to interest rate fluctuation risk. However, interest rate swaps are used to hedge the interest rate fluctuation risk on some borrowings.」

    The company continues to disclose the variable interest rate risk on borrowings for capital expenditures and hedging through interest rate swaps.
  16. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  17. FY2019-Q2RestatedAnnual report

    「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  18. FY2019-Q1RestatedAnnual report

    「There were no newly identified business or other risks during the first quarter of the fiscal year. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no new developments or material changes in the interest rate fluctuation risk on borrowings or its hedging through interest rate swaps.
  19. FY2018First statedAnnual report

    「Borrowings are primarily used to finance capital expenditures, and most are at variable interest rates, exposing the company to interest rate fluctuation risk. However, interest rate swaps are used to hedge the interest rate fluctuation risk on some borrowings.」

    The company recognizes that borrowings for capital expenditure are exposed to variable interest rate risk and uses interest rate swaps for some borrowings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Haba Laboratories's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.